Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats

Int J Exp Pathol. 1990 Oct;71(5):671-5.

Abstract

In the present study, lipoprotein metabolism was investigated during compensatory hyperplasia of bone marrow after haemolysis induced by phenylhydrazine (20 mg/kg b.w.) administration in rats. The rats were sacrificed at different time intervals (0, 1, 2 and 5 days) after phenylhydrazine treatment. Analysis of the different fractions of lipoproteins has shown that during bone marrow hyperplasia there is an alteration of lipoprotein profiles, mainly due to a decrease of HDL2 and HDL3 subfractions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / pathology*
  • Cholesterol, HDL / blood*
  • Hemolysis / drug effects
  • Hyperplasia / blood
  • Male
  • Phenylhydrazines
  • Rats
  • Rats, Inbred Strains

Substances

  • Cholesterol, HDL
  • Phenylhydrazines